Michael Rainone

466 total citations
8 papers, 83 citations indexed

About

Michael Rainone is a scholar working on Oncology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Rainone has authored 8 papers receiving a total of 83 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Genetics and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Rainone's work include Chronic Lymphocytic Leukemia Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Michael Rainone is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Michael Rainone collaborates with scholars based in United States. Michael Rainone's co-authors include Erin Salo‐Mullen, Eileen M. O’Reilly, Zsofia K. Stadler, Vinod Pullarkat, Lihua E. Budde, Dat Ngo, John H. Baird, Ibrahim Aldoss, Myo Htut and Joanne Mortimer and has published in prestigious journals such as Journal of Clinical Oncology, The Oncologist and JAMA Oncology.

In The Last Decade

Michael Rainone

8 papers receiving 82 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Rainone United States	4	66	29	19	18	15	8	83
Ekaterina Postovalova United States	6	33 0.5×	27 0.9×	27 1.4×	15 0.8×	27 1.8×	25	98
R. Scott Mead Australia	5	48 0.7×	29 1.0×	28 1.5×	10 0.6×	13 0.9×	5	91
Siarhei Kandabarau Germany	4	32 0.5×	24 0.8×	22 1.2×	25 1.4×	30 2.0×	14	82
Erin E. Tapper United States	5	61 0.9×	10 0.3×	34 1.8×	11 0.6×	13 0.9×	13	75
Fanny Fouyssac France	3	54 0.8×	13 0.4×	9 0.5×	24 1.3×	56 3.7×	4	97
Martina Gropp‐Meier Germany	6	90 1.4×	9 0.3×	21 1.1×	15 0.8×	30 2.0×	17	130
Alice Piapi United Kingdom	5	49 0.7×	15 0.5×	37 1.9×	19 1.1×	28 1.9×	8	96
Zhiyuan Chu China	4	62 0.9×	19 0.7×	78 4.1×	23 1.3×	20 1.3×	4	137
Valentina A. Zavala United States	4	54 0.8×	51 1.8×	44 2.3×	22 1.2×	21 1.4×	8	118
Seishi Ogawa Japan	5	31 0.5×	14 0.5×	58 3.1×	10 0.6×	24 1.6×	26	114

Countries citing papers authored by Michael Rainone

Since Specialization

Citations

This map shows the geographic impact of Michael Rainone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rainone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rainone more than expected).

Fields of papers citing papers by Michael Rainone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Rainone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rainone. The network helps show where Michael Rainone may publish in the future.

Co-authorship network of co-authors of Michael Rainone

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Rainone. A scholar is included among the top collaborators of Michael Rainone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Rainone. Michael Rainone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Rainone, Michael, Carolyn E. Behrendt, Saro Kasparian, et al.. (2023). HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia. Breast Cancer. 30(5). 796–801. 3 indexed citations

Rainone, Michael, Saro Kasparian, Tina Nguyen, et al.. (2023). Thrombopoietin Receptor Agonists for Thrombocytopenia Secondary to HER2-Targeted Antibody Drug Conjugates. The Oncologist. 28(9). e843–e846. 2 indexed citations

Rainone, Michael & Tanya Siddiqi. (2022). Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies. Current Hematologic Malignancy Reports. 17(1). 39–45. 1 indexed citations

Zheng-Lin, Binbin, Michael Rainone, Anna M. Varghese, et al.. (2022). Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma. Molecular Diagnosis & Therapy. 26(6). 645–653. 6 indexed citations

Rainone, Michael, Carolyn E. Behrendt, Saro Kasparian, et al.. (2022). HER2-targeted immunoconjugates for breast cancer: Ancestry and dose adjustment for thrombocytopenia.. Journal of Clinical Oncology. 40(16_suppl). 1048–1048. 1 indexed citations

Rainone, Michael, Dat Ngo, John H. Baird, et al.. (2022). Interferon-γ blockade in CAR T-cell therapy–associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis. Blood Advances. 7(4). 533–536. 31 indexed citations

Rainone, Michael, et al.. (2020). An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice. JAMA Oncology. 6(5). 764–764. 38 indexed citations

Rainone, Michael, et al.. (2013). Central and peripheral nervous system involvement as a manifestation of graft versus host disease after liver transplantation: case report. Journal of the Peripheral Nervous System. 18. 20–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact